Cargando…
ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
For the young breast cancer population in India, the burden of hereditary breast cancer is not well defined. Moreover, genetic testing criteria (National Comprehensive Cancer Network and Mainstreaming Cancer Genetics (MCG) plus) have never been validated for the Indian population. Therefore, this st...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519625/ https://www.ncbi.nlm.nih.gov/pubmed/34654988 http://dx.doi.org/10.1245/s10434-021-10880-8 |